2018
DOI: 10.1093/ehjci/jey067
|View full text |Cite
|
Sign up to set email alerts
|

Echocardiographic-fluoroscopic fusion imaging for transcatheter mitral valve repair guidance

Abstract: The echocardiographic-fluoroscopic fusion imaging is a new imaging system which has recently become available, with the proposal to facilitate catheters and device navigation during catheter-based structural heart disease interventions. Several reports have described the early developments and the first clinical experiences, but literature focusing on the practical applications of fusion imaging technology to mitral valve transcatheter interventions, and on its potential advantages and current limitations, is … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
21
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(22 citation statements)
references
References 22 publications
0
21
0
1
Order By: Relevance
“…However, as treatment focus shifts to include MitraClip for secondary MR in patients with compromised left ventricular function, mild–moderate pulmonary hypertension, multi‐valvular heart disease, etc., steps to minimize overall procedure time will be critical to ensuring programmatic success. Furthermore, there are increasing experience with “fusion” imaging whereby fluoroscopy is coupled with noninvasive imaging for MitraClip and other structural heart therapies 17 . As with the use of adjunctive fluoroscopy technique in this manuscript, the relative impact of increased fluoroscopy time and increased radiation exposure will have to be weighed against the benefit of improved procedural outcomes and increased procedural efficiencies.…”
Section: Discussionmentioning
confidence: 99%
“…However, as treatment focus shifts to include MitraClip for secondary MR in patients with compromised left ventricular function, mild–moderate pulmonary hypertension, multi‐valvular heart disease, etc., steps to minimize overall procedure time will be critical to ensuring programmatic success. Furthermore, there are increasing experience with “fusion” imaging whereby fluoroscopy is coupled with noninvasive imaging for MitraClip and other structural heart therapies 17 . As with the use of adjunctive fluoroscopy technique in this manuscript, the relative impact of increased fluoroscopy time and increased radiation exposure will have to be weighed against the benefit of improved procedural outcomes and increased procedural efficiencies.…”
Section: Discussionmentioning
confidence: 99%
“…An expert consensus statement on core competencies in echocardiography for imaging in structural heart disease interventions published recently emphasizes the need for a distinct educational training pathway for interventional echocardiography specialists, being a fully integrated part of the procedural team to facilitate optimal results 14 . Furthermore, availability of real time fusion imaging (integration of TEE or CT in fluoroscopic visualization) has enriched advanced guidance for transcatheter structural heart interventions (eg, 15,16 ). Nevertheless, implementation of MPR in 3DTEE might be the key to optimal true axis visualization of soft tissue structures in the context of these contemporary developments.…”
Section: Discussionmentioning
confidence: 99%
“…CT and fluoroscopic fusion imaging have also been applied to LAA occlusion 5 . Intraprocedural TEE and fluoroscopy can also be fused to allow 3D visualization of cardiac anatomy for a number of different procedures including perivalvular leak closure, MitraClip (Abbott Laboratories), and Cardioband (Edwards Lifesciences) 6 . Recently, TEE and fluoroscopic fusion has been reported for LAA occlusion with the Amulet device (Abbott Laboratories) 7 .…”
Section: Discussionmentioning
confidence: 99%